Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...
Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...
Researchers studied the relationship between 3 dermatological immune-mediated inflammatory diseases and COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback